INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹66 Cr | ₹66 Cr | ₹1.36 Cr | ₹4.24 Cr | ₹36 Cr |
What is the latest Contingent Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹66 Cr |
| Mar2025 | ₹66 Cr |
| Mar2024 | ₹1.36 Cr |
| Mar2023 | ₹4.24 Cr |
| Mar2022 | ₹36 Cr |
How is Contingent Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹66 Cr | -0.11 | |
| Mar2025 | ₹66 Cr | 4,804.35 | |
| Mar2024 | ₹1.36 Cr | -68.05 | |
| Mar2023 | ₹4.24 Cr | -88.11 | |
| Mar2022 | ₹36 Cr | - | |
Compare Contingent Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹2,801.8 Cr | -9.4% | -8.5% | 230.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | -9.4% |
-8.5% |
230.9% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses